Projects per year
Organization profile
Organization profile
The Institute for Translational Sciences (ITS) aims to train a new generation of clinical and translational researchers, engage stakeholders and communities in research, address barriers to clinical and translational research, and advance translational research through team-based approaches. The ITS, established in 2007, is the academic home of UTMB’s Clinical Translational Sciences Award (CTSA), funded by the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS). CTSA institutions work together to speed the translation of research discoveries into improved health.
David Urban, Director
Fingerprint Dive into the research topics where Institute for Translational Research is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Respiratory Syncytial Viruses
Medicine & Life Sciences
Vaccines
Medicine & Life Sciences
Respiratory Syncytial Virus Infections
Medicine & Life Sciences
Epithelial Cells
Medicine & Life Sciences
Cyclin-Dependent Kinase 9
Medicine & Life Sciences
Attenuated Vaccines
Medicine & Life Sciences
Proteins
Medicine & Life Sciences
Viruses
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Bill Ameredes, PhD
- Internal Medicine - Professor
- Pharmacology & Toxicology - Professor
- Sealy Center for Environmental Health Medicine - Member
- Biochemistry & Molecular Biology - Professor
- Institute for Translational Research - Member
Person: Academic
Alan Barrett, PhD
- Pathology - Professor
- Pediatrics - Professor
- Microbiology And Immunology - Professor
- Institute for Translational Research - Member
Person: Academic
Suresh Bhavnani, PhD, MArch
- Preventive Medicine & Community Health - Professor
- Institute for Translational Research
- Rehabilitation Sciences - Adjunct Professor
Person: Academic
Projects 2015 2024
- 7 Active
RSVP of Galveston County
Corporation for National & Community Ser
9/1/19 → 3/31/20
Project: Other project
Michigan Predictive Activity & Clinical Trajectories (MiPACT) Study
9/1/19 → 2/29/20
Project: Other project
ASPirin in Reducing Events in the Elderly eXTenison
Hennepin Healthcare Research Institute
7/15/19 → 4/30/24
Project: Other project
Research Output 1994 2019
1
Citation
(Scopus)
A Phase I Randomized Clinical Trial of Evidence-Based, Pragmatic Interventions to Improve Functional Recovery After Hospitalization in Geriatric Patients
Deer, R., Dickinson, J. M., Baillargeon, J., Fisher, S., Raji, M. & Volpi, E., Sep 15 2019, In : The journals of gerontology. Series A, Biological sciences and medical sciences. 74, 10, p. 1628-1636 9 p.Research output: Contribution to journal › Article
Open Access
Clinical Trials, Phase I
Geriatrics
Hospitalization
Randomized Controlled Trials
Placebos
1
Citation
(Scopus)
Apigenin Decreases Acinar Cell Damage in Pancreatitis
Mrazek, A. A., Bhatia, V., Falzon, M., Spratt, H., Chao, C. & Hellmich, M., May 1 2019, In : Pancreas. 48, 5, p. 711-718 8 p.Research output: Contribution to journal › Article
Apigenin
Acinar Cells
Pancreatitis
Parathyroid Hormone-Related Protein
Transforming Growth Factors
Attenuation of live-attenuated yellow fever 17D vaccine virus is localized to a high-fidelity replication complex
Davis, E. H., Beck, A. S., Strother, A. E., Thompson, J. K., Widen, S. G., Higgs, S., Wood, T. G. & Barrett, A. D. T., Jan 1 2019, In : mBio. 10, 5, e02294.Research output: Contribution to journal › Article
Open Access
Yellow Fever Vaccine
Attenuated Vaccines
Viruses
Vaccines
Ribavirin
Prizes
Scholar, Translational Research Scholar Program
Tomoko Makishima (Recipient), Aug 2010
Prize: Other distinction